MapmyGenome India Awarded CE Certificate for Spoligo TB™ In Vitro Diagnostic Test Kit
Hyderabad, India — May 6, 2015: MapmyGenome India announced that their Spoligo TB™ in vitro diagnostic test kit for speedy detection and typing of large numbers of TB samples has been awarded the CE Certificate. With this milestone, the kit is set to enter the global market as a diagnostic device.
“Spoligo TB™ has been one of our most consistent performers and now we can take this further to diagnostic labs across the globe. CE certification is a key milestone in achieving our vision of better health for India (and globally) using technology.” — Anu Acharya, CEO, MapmyGenome
About CE Certified Spoligo TB™ Kit
CE certified Spoligo TB™ is an effective PCR-based method to simultaneously detect and categorise Mycobacterium tuberculosis complex. It utilises DNA polymorphism at the Direct Repeat (DR) region, which is unique to Mycobacterium tuberculosis complex bacteria. Researchers have proven this test is superior to traditional tests such as Southern blotting, IS6110 fingerprinting, tuberculin skin test, culture, and sputum smear microscopy in terms of accuracy, sensitivity, specificity, simplicity, throughput, costs, scale, and diagnosis time.
The kit finds applications in clinical samples, urban and rural labs for TB surveillance, and in large-scale epidemiological control — in prison outbreaks, hospitals, and other closed communities. It can also be used to screen TB infections in HIV patients.
About MapmyGenome India
MapmyGenome India offers services in personal genomics, molecular diagnostics, DNA forensics, and brain wellness. As pioneers of personal genomics in India, they created a new market for predictive tests with their flagship brand Genomepatri™ in April 2013. In February 2014, the Government of Karnataka awarded them the Bio Excellence award “Emerging Company of the Year”. In March 2015, they raised a US$1.1 million Pre-Series A round of funding.
MapmyGenome — Better Health Through Technology
From TB diagnostics to personal genomics, MapmyGenome is India’s pioneer in DNA-based health solutions. Genomepatri covers 100+ health conditions, nutrition, fitness, and drug response traits — all from a simple saliva sample.
